iqvia weight loss prescriptions semaglutide tirzepatide q3 2024 glp-1 The FDA has approved the first pill version 2024: The obesity market's inflection

When paired with thoughtful supplements, coaching, or medical treatment when needed, food-based strategies that include foods that boost GLP-1 can be powerful allies for appetite control and blood-sugar stability

Overcoming these barriers is essential to bridge the divide between proof-of-concept and clinical application

This is the single most-supported protective move (Memel 2025)

For rarer disorders such as PTSD and bulimia nervosa, significant findings were limited to a single database (FinnGen), emphasizing the need for validation in independent cohorts to confirm these preliminary associations

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target